Researchers seek powerful antibody against many variants; breakthrough cases may be less infectious

Brasil Notícia Notícia

Researchers seek powerful antibody against many variants; breakthrough cases may be less infectious
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Reuters
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 97%

Here is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

Two separate research teams last week reported on laboratory tests of monoclonal antibodies that appear to protect against a broad range of COVID-19 virus variants. One study, published on Wednesday in, identified "high-level, broad-spectrum" antibodies in blood samples from survivors of the original SARS outbreak in 2003 who recently received the Pfizer/BioNTech vaccine against SARS-CoV-2, the virus that causes COVID-19.

on Saturday ahead of peer review, they conclude that shedding of infectious virus is reduced in breakthrough cases, although patients are still contagious.Protective antibody levels decline faster in recipients of the mRNA COVID-19 vaccine from Pfizer/BioNTech than in COVID-19 survivors, according to doctors at one of Israel's largest HMOs. They tracked antibody levels in 2,653 adults who received two doses of the vaccine and in 4,361 COVID-19 survivors who were never vaccinated.

that breakthrough infection rates increase starting about five months after vaccination. Dr. Israel said the combined data argues for a booster shot five months after the second injection, especially for high-risk individuals.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Reuters /  🏆 2. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

WHO Leader Pleads Against Booster Shots—Questioning Efficacy And Highlighting Risk Of ‘More Potent’ VariantsWHO Leader Pleads Against Booster Shots—Questioning Efficacy And Highlighting Risk Of ‘More Potent’ VariantsI'm a British-born reporter covering breaking news for Forbes.
Consulte Mais informação »

How Australia went from being a 'Covid-free paradise' to 'a mess'How Australia went from being a 'Covid-free paradise' to 'a mess'With the delta variant now seeping around the country, more than half of Australia's 25M people are in lockdown, and a slow vaccination program has left many demanding to know what went wrong.
Consulte Mais informação »

Monoclonal antibody treatment orders rapidly increasing in COVID surge statesMonoclonal antibody treatment orders rapidly increasing in COVID surge statesThe use of monoclonal antibodies as a way to prevent people from getting very sick with COVID-19 is rapidly increasing — alongside the grim statistics on surging infection rates across the country.
Consulte Mais informação »

Many School Districts Keep Covid-19 Closure Thresholds FlexibleMany School Districts Keep Covid-19 Closure Thresholds FlexibleMany districts across the U.S. are taking a wait-and-see approach to school closures as the Delta variant continues to spread. “There’s no magic number.”
Consulte Mais informação »

Hilary Duff Reveals Positive COVID DiagnosisHilary Duff Reveals Positive COVID DiagnosisHilary Duff Reveals Positive COVID Diagnosis “That delta... she's a little b*tch.' HilaryDuff
Consulte Mais informação »



Render Time: 2025-04-18 14:22:29